ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 14 analysts with an average price target of $43.53. This is a potential upside of $20.24 (86.9%) from yesterday's end of day stock price of $23.29.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 149 price targets and 142 ratings on display. The stock rating distribution of ARWR is 81.4% BUY and 18.6% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.4% with an average time for these price targets to be met of 258.89 days.

Highest price target for ARWR is $90, Lowest price target is $34, average price target is $43.53.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 08-Feb-2024. First documented stock forecast 05-Mar-2014.

Currently out of the existing stock ratings of ARWR, 35 are a BUY (81.4%), 8 are a HOLD (18.6%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$66.71 (286.43%)

90

2 months 17 days ago

0/10 (0%)

$59.15 (191.73%)

Hold

34

$10.71 (45.99%)

33

2 months 18 days ago

3/4 (75%)

$2.35 (7.42%)

69

Buy

50

$26.71 (114.68%)

50

2 months 18 days ago

2/8 (25%)

$18.35 (57.98%)

100

Buy

51

$27.71 (118.98%)

29

3 months 15 days ago

1/2 (50%)

$11.55 (29.28%)

15

Buy

47

$23.71 (101.80%)

80

8 months 17 days ago

6/7 (85.71%)

$19.51 (70.97%)

125

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 258.89 days on average for the stock forecasts to be realized with a an average price target met ratio 65.4

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 4 price targets and 3 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $75.13

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?